Completed

Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Cancer

+ HIV
Until 99 Years

See all eligibility criteria

How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: January 1992

See protocol details

Summary

Principal SponsorNational Cancer Institute (NCI)
Last updated: December 17, 2019
Sourced from a government-validated database.Claim as a partner
Study start date: January 29, 1992Actual date on which the first participant was enrolled.

This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol. Background: It may be in the interest of the CCR to continue to follow and treat certain subjects after they have completed their treatment and participation on a research protocol. Objective: To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for another active research protocol. Eligibility: Subjects who have been previously enrolled on and received treatment according to an approved CCR research protocol. (clinical trial) It is in the best interest of the subject and the CCR for the subject to continue to receive standard care and follow-up at the NIH. Design: Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on an active research protocol. No investigational treatments will be administered. This protocol is not be used as a platform to perform pilot studies of off-label uses for standard agents.

Official TitleContinuing Treatment for Children and Adults in the Center for Cancer Research 
Principal SponsorNational Cancer Institute (NCI)
Last updated: December 17, 2019
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
2145 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.
Cohort
These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

How information is collected
Researchers start collecting data from the present day forward, following participants over time to observe outcomes. This approach helps identify how exposures or behaviors may lead to health events in the future.Other Ways to Collect Data
Retrospective: These studies use existing medical records or past data.
Cross-sectional: These studies collect data at one single point in time.
Others: Some studies use a mix of approaches or less common designs depending on the research goal.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Until 99 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Cancer
HIV
Criteria

* INCLUSION CRITERIA: Subjects of any age who have been previously enrolled and treated on an approved CCR research treatment protocol. It is in the best interests of the subject and the CCR for the subject to continue to receive treatment and follow-up at the NIH. The subject or guardian signs the informed consent and agrees to the proposed treatment regimen. EXCLUSION CRITERIA: Subjects who have not been previously treated on a CCR research treatment protocol. Subjects who are receiving an investigational therapy.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives
Study Objectives
Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Suspended
National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, United StatesSee the location
CompletedOne Study Center